This study examined the relationship between receptor binding of insulin in a metabolically significant target tissue in vitro and sensitivity to insulin in vivo in obese human subjects. Specific insulin binding was measured at 24 degrees C in isolated enlarged fat cells obtained from 16 patients, by observing the effect of increasing concentrations of unlabeled insulin on the binding of [125I]insulin. Scratchard plots of the binding data were curvilinear with an upward concavity, similarity shaped, and essentially parallel. Kinetic studies on the dissociation of [125I]insulin from fat cells indicated that these curvilinear Scratchard plots could be explained by the presence of site:site interactions of the negative cooperative type. Differences in binding between individual patients were predominantly due to differences in the numbers of receptor sites whether expressed in relation to cell number, cell volume, or cell surface area. These findings were not accounted for by differences in [125I]insulin degradation. Acute exposure of adipose tissue to insulin in vitro had no significant effect on [125I]insulin binding to isolated cells. The number of receptor sites was directly correlated with insulin sensitivity in vivo, measured as the rate constant (Kitt) for the fall in blood glucose after intravenous insulin, and was inversely correlated with the level of fasting plasma insulin. These findings corroborate those from other studies using human mononuclear leukocytes and various […] 
A B S T R A C T This study examined the relationship between receptor binding of insulin in a metabolically significant target tissue in vitro and sensitivity to insulin in vivo in obese human subjects. Specific insulin binding was measured at 24°C in isolated enlarged fat cells obtained from 16 patients, by observing the effect of increasing concentrations of unlabeled insulin on the binding of [1251] insulin. Scatchard plots of the binding data were curvilinear with an upward concavity, similarly shaped, and essentially parallel. Kinetic studies on the dissociation of [1251]insulin from fat cells indicated that these curvilinear Scatchard plots could be explained by the presence of site:site interactions of the negative cooperative type. Differences in binding between individual patients were predominantly due to differences in the numbers of receptor sites whether expressed in relation to cell number, cell volume, or cell surface area. These findings were not accounted for by differences in [125I]insulin degradation. Acute exposure of adipose tissue to insulin in vitro had no significant effect on [1251] insulin binding to isolated cells. The number of receptor sites was directly correlated with insulin sensitivity in vivo, measured as the rate constant (K111) for the fall in blood glucose after intravenous insulin, and was inversely correlated with the level of fasting plasma insulin. These findings corroborate those from other studies using human mononuclear leukocytes and various tissues from the obese mouse, which indicate that decreased insulin binding is a characteristic feature of insulin resistance in obesity. INTRODUCTION Obesity is characterized by hyperinsulinemia both in the basal state and after various insulin secreta-Received for publication 10 May 1976 and in revised formn 16 August 1976. gogues, and by tissue resistance to the action of 1)oth endogenous and exogenous insulin (1) . The initial step in the action of insulin is its interaction with specific receptors on the surface membrane of the cell (2) . Recently, a number of in vitro studies have shown that obesity in animals is associated with a decrease in the concentration of nonnal insulin receptors on cell membranes (3) . This phenomenon has been demonstrated in the plasma membranes of fat cells (4), liver cells (5, 6) , and cardiac muscle (7) as well as in thymic lymphocytes (8) from the obese hyperglycemic (ob/ob) mouse, and in isolated fat cells from rats with acquired obesity (9) . A defect in insulin binding to circulating mononuclear leukocytes from obese humans (10) has recently been shown to be due to a decrease in receptor concentration (11) . However the role of the insulin receptor in human obesity has not been extensively studied in metabolically significant target tissues. Olefsky et al. (12) first described the characteristics of insulin binding to human fat cells. Amatruda et al. (13) then reported that contrary to the results in monocytes, there was no difference in insulin binding per fat cell between obese and normal weight subjects. However, one brief symposium report by Marinetti et al. (14) had earlier suggested that insulin binding to fat cells from obese subjects was decreased.
The present study was designed to examine the relationships between insulin-receptor' binding in isolated fat cells from obese subjects and indices of insulin sensitivity in these subjects, and to further characterize the nature of insulin binding to human fat cells. Insulin binding studies. Abdominal subcutaneous adipose tissue samples were obtained at the beginning of operation in all subjects (including J. A.) on the 8th day, after a 12-14-h overnight fast. General anesthesia was in-2Abbreviations used in this paper: Bm.ax, insulin specifically bound at an insulin concentration of 16.7 nM; Kitt, rate constant for the fall in blood glucose; Ro, maximal binding capacity. duced with a barbiturate derivative and was maintained with a N2O-halothane-02 mixture. Tissue was collected and washed in warm (370C) Krebs-Ringer-bicarbonate buffer, pH 7.4, containing 54 mg/100 ml glucose and 1% insulin-free human albumin (Commonwealth Serum Laboratories, Melbourne, Australia). This buffer was used for all procedures, including binding studies. Isolated fat cells were prepared according to the method of Rodbell (18) and washed three times by flotation in buffer at 240C before use. [125I]Insulin was prepared from human monocomponent insulin (Novo Research Institute), by a modification of the chloramine-T method (19) and separated from free 1on a cellulose column (20) . This preparation was further purified by Sephadex G-50 chromatography (South Seas, Pty. Ltd., North Ryde, N. S. W., Australia) to remove a high molecular weight component. The specific activity of the purified [125I]insulin, determined by radioimmunoassay, was 120-150 ,uCi/,ug (average of 0.4-0.5 iodine atoms per insulin molecule). Its biological activity (conversion of [1-14C]glucose to 14CO2 by isolated rat fat cells) was identical with that of unlabeled human insulin.
METHODS
Binding studies were performed in 5-ml polyethylene tubes; 0.3 ml of fat cell suspension (1.3-3.3 x 105 cells/ml) was added to 0.2 ml of buffer containing [i251]insulin (final concentration 0.011-0.125 nM) and unlabeled human insulin in a final concentration range up to 0.67 ,uM. Incubations were performed in triplicate at each concentration of unlabeled insulin. The tubes were gently shaken for 30 min at 240C and then rapidly cooled in iced water. Fat cells were immediately separated from the incubation medium by centrifuging 0.3-ml aliquots of each incubate through dinonyl phthalate in Beckman microfuge tubes (Beckman Instruments, Inc., Fullerton, Calif.), according to the method of Gliemann (21) . Bound radioactivity in the excised cells and free radioactivity in an aliquot of the infranatant was measured in a gamma counter. Insulin degradation was estimated by measuring the ability of 1436 L. C. Harrison, F. I. R. Martin, and R. A. Melick
[125I]insulin in an aliquot of the infranatant to precipitate with 10%o TCA or to bind to excess antiinsulin antibody, compared with that of [1251]insulin not incubated with cells. The maximum radioactivity bound to the cells ranged from 0.3 to 7.9%o of the tracer [il-Iinsulin (mean 2.1%), of which 10-20% was nonspecifically bound, i.e., nondisplaceable by the highest concentration of unlabeled insulin used (0.67 ,M). Blank binding (in the absence of cells) was always insignificant. Specific, receptor-bound radioactivity was calculated as the difference between total and nonspecific-bound radioactivity. Binding was normalized to a standard cell number (109) on the basis that specific binding of tracer concentrations of ['25I]insulin was a linear function of cell number up to 3.1 x 105 cells/ml, the maximum concentration tested (data not shown). It should be noted that the insulin concentration of the extracellular phase (including the contribution of [l251]insulin mass) was determined by correcting the incubation suspension for fat cell volume, before calculating binding results for each subject.
Fat cell size and viability and lipid mass were estimated as previously described (22) . [1251] insulin radioactivity was used to calculate the total amount of insulin specifically bound at each concentration of unlabeled insulin used and a series of binding curves obtained (Fig. 1) . The most obvious difference between subjects is in the amount of insulin bound for a given insulin concentration; this suggests that individual subjects differed in the number of receptors per cell able to bind insulin. This conclusion is supported by Scatchard analysis (23) of the binding data (Fig. 2) . When the bound/free insulin is expressed as a function of the bound insulin, a series of similarly shaped, essentially parallel curves are obtained. These types of Scatchard plots, concave upwards, indicate a decreasing affinity of the insulin receptor population as fractional saturation increases. They may result from the presence of two or nmore discrete populations of receptors with differing affinities (24), from site:site interactions of the negative cooperative type (25) , or from both. De Meyts and Roth have demonstrated that dissociation of [1251]insulin caused by infinite dilution is enhanced by the addition of unlabeled insulin, a finding consistent with a negative cooperative model in which a homogenous population of insulin receptors switches from a high to a low affinity state as receptor occu-Insulin Binding and Insulin Sensitivity in Obesity ........... '. pancy increases. The dissociation rate of [1251]insulin from human fat cells was significantly greater with dilution plus unlabeled insulin (83 nM) than with dilution alone (Fig. 3) , indicating that the cturvilinear Scatchard plots (Fig. 2 ) couild be explained, at least in part, by the presence of negative cooperativity. Under such circumstances, the estimation of binding affinities becomes difficult (26) . It can be seen, however, (Fig. 2 ) that for a given fractional saturation the slopes of the curves are approximately the same; this parallelism reflects similar apparent binding affinities between subjects.
RESULTS
In the presence of cooperativity, the Hill plot (27) provides a method for assessing the average affinity and for estimating cooperative interactions. Data for the majority of subjects (11/16) were superimposable ( Fig. 4 ). All lines had a slope (Hill coefficient) of 0.88; slopes of less than 1 are consistent with negative cooperativity. When the untransformied binding data for all subjects were examined, the insulin concenitrationi causing 50% inhibition of specific [125I]1 insulin binding was 1.26±0.10 nXI (mean±+SSEM). figure) as described in the legend to Fig. 1 . The cells were then allowed to float to the surface and their infranatant medium aspirated via a thin catheter. The cells were washed twice with cold (4°C) buffer and the stuspension divided into two 10-mI lots. Cold buffer was aspirated from each and replaced with 20 ml of buffer at 24°C, containing in one case 83 nM of unlabeled insulin. Duplicate 400-,lI aliquots were then removed from each of the stirred suspensions at 2, 5, 10, 20, 30, and 60 min for measurement of cell-bound radioactivitv. Nonspecific binding, determined in identical experiments in which the incubation mixture also contained 16.5 uM of unlabeled insulin, amounted to 20% of the total binding. Approximately onehalf of the nonspecifically bound counts dissociated within the first 2 min; the remainder showed no tendancy to dissociate with time in the presence or absence of unlabeled insulin. The binding capacity (receptor number) for each subject was estimated: (a) as maximal binding capacity, Ro by extrapolation ofthe Scatchard plot to the abscissa, (26) , and (b) as insuilin specifically bound, Bmax, at an insulin concentration of 16.7 nM ( Fig. 1 ) (Table I) 
.3
Relationships of fat cell insulin binding to insulin sensitivity in vivo. There was an inverse correlation between fasting plasma insulin and both B0 (r = -0.65, P < 0.01, n = 16) and Bmax (r = -0.66, P < 0.01, n = 16), and a direct correlation between Ki,, and both RB (r = 0.93, P < 0.001, n = 15) and Bmax (r = 0.82, P < 0.001, n = 15). These relationships for Bmax are shown in Fig. 5 . Neither of the in vitiro binding parameters was correlated with the insulin area under the oral glucose tolerance curve or with the insulinogenic index. Fat cell volume 3Bmax should be roughly proportional to the maximal binding capacity. It was chosen as an operational value because of the difficulty in precisely estimating Bo. The contribution of nonspecific binding to total binding at high concentrations of unlabeled insulin is fractionally greater, and specific binding is difficult to determine accurately above an insulin concentration of 16.7 nM. Furthermore, it is not possible to be sure that the terminal points of the Scatchard plot have been accurately extrapolated to the abscissa.
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L. C. Harrison, F. I. R. Martin, and R. A. Melick was inversely related to both B0 (r = -0.62, P = 0.01, n = 16) and B,,ax (r = -0.63, P < 0.01, n = 16). There was no relationship between age or relative weight and cell binding. The in vivo indices of insulin sensitivity (fasting plasma insulin, Kitt, insulin area, and insulinogenic index) showed no relationship to the concentration of insulin required to produce 50% inhibition of specific [125I ]insulin binding.
The differences between subjects and the relationships described above were present when binding was expressed not only on a cell basis (per 109 cells), but also on the basis of cell surface area or cell volume.
Insulin degradation vs. insulin binding. Insulin degradation assessed by binding to excess anti-insulin antibody was consistently greater than when assessed by TCA precipitation, and averaged 11.8% (range 0-20%). Binding data were not corrected for insulin degradation. Differences in insulin binding between subjects could not be accounted for by differences in insulin degradation.
Acute effect of ambient insulin levels of fat cell binding. To ascertain whether the differences in binding capacity between patients could be due to occupation of receptors by insulin in the plasma at the time of biopsy, the following experiment was performed. Adipose tissue pieces were divided into two lots and preincubated with and without unlabeled insulin (0.83 nM) for 1 h at 37°C. The tissues were washed, isolated cells were prepared, and binding studies were performed in the routine manner. In three such experiments there was no significant difference in binding capacity between cells from tissues preincubated with and without insulin.
DISCUSSION
A number of studies in animals (see review, [3] ) indicate that a decrease in the number of insulin receptors per cell is a characteristic feature of insulin resistance in obesity. In human obesity, Archer et al. (10) reported that insulin binding to circulating monocytes was decreased; this has recently been shown by Bar et al. (11) to be due to a decrease in insulin receptor concentration. A brief report by Marinetti et al. (14) had earlier described decreased insulin binding to fat cells from obese subjects, but Amatruda et al. (13) were unable to confirm this. The present study has shown that the number of insulin receptors on fat cells is directly related to insulin sensitivity in obese humans. This finding is not surprising, since the changes in insulin binding in obese animals are present not only in circulating monocytes but also in liver, fat, and muscle (3) . The insulin receptor was here defined purely in terms of specific physicochemical binding. It is reasonable, though, to assume that we are dealing with a site which mediates the biological action of insulin, since Ktt correlated with insulin binding and since Ktt has previously been shown (28) to correlate with the insulin sensitivity of glucose oxidation in adipose tissue from obese subjects. Our findings support the emerging concept that a decreased cell concentration of receptors is related to a decreased effect of insulin in obese subjects and are consistent with the hypothesis that plasma insulin modulates the concentration of its own receptors in target tissues (3, 6) .
Our results contrast with those of Amatruda et al. (13) who failed to demonstrate a difference in fat cell insulin binding between groups of normal and obese subjects. Their measurement of binding by competition of increasing amounts of unlabeled insulin with [1251] insulin is similar in principle to ours, except that they reacted cells with a much higher concentration of tracer [125I]insulin (4.8 nM) before the addition of unlabeled insulin. Fat cell insulin sensitivity (29) and insulin binding (6, 10) are closely Insulin Binding and Insulin Sensitivity in Obesity related to diet. Thus, receptor deficiency in obesity can be partially corrected by chronic calorie restriction with a fall in plasma insulin (6, 10) ; by contrast, receptor affinity rather than number is increased in obese subjects by an actute 72-h fast (11) . It is therefore possible that antecedent dietary conditions, not specifically stated by Amatruda et al. (13) , could account for these discrepant results with humilan fat cells. The presentation of their data does not allow direct comparison with our results and we therefore cannot reconcile them. However, both studies indicate that the number of insulin receptors per unit of surface area is reduced in large cells, the more so in the present study where the number of receptors per cell or per unit volume of cell lipid is also reduced.
Our study design does not allow us to examine independently the effects of fat cell size and plasma insulin on insulin binding. Recent evidence, however, suggests that cell size is not a primnary determinant of insulin sensitivity (29) and that insulin binding is more a functioni of the prevailing plasma insuliin level than body weight or fat cell size (6, 9) .
There are obvious difficulties in determining the reproducibility of binding data in individual humian subjects. A repeat experiment was performed in only one patient (J. A.) and showed, with the same preoperative conditions and plasmia insulin level, ain identical binding curve (data not shown). In any case, lack of reproducibility of binding curves would tend to obscure relationships, rather than produce them artificially. On the other hand, a numllber of factors could have catused artifactuLial differences between patients. Anesthetic agents, by their very natture, alter ceitain membrane properties and are concentrated in fat; they should be considered as a possible influence on binding results. Our subjects, however, were exposed to the same anesthetics for a similar period. Indirect evidence for the absence of a significant anesthetic effect is that the insulin-stimulated glucose oxidation rate in fat obtained under the present conditions was similar to that in fat obtained under local 1% lignocaine skin anesthesia (22) . Differences in cell populations (apart from cell size) were excluded by always using subcutaneous adipose tissue from the anterior abdominal wall. Adipose tissue was digested with the same batch of collagenase and treated identically in all cases. Cell viability was checked routinely when sizing cells (22) . Although receptor degradation was not measured in each case, previous studies (unpublished) showed that this was not significant for 1-2 h after washing collagenaseliberated cells, and then progressed with a half-time of degradation of 4-6-h. Olefsky et al. (12) obtained similar results when first describing the characteristics of insulin binding to human fat cells. On this basis the timing of the binding experiments would have excluded any significant effect of receptor degradation, although differences between individual subjects could still be present. 1251-insulin degradation was miieasuiired in each case aiid was shown to bear Ino relationship to differences in binding between subjects. The absence of an accute effect of inlsUilin oI binding has been shown previously (5, 6, 8, 10) . The lack of effect of insuliin preincubatted witlh adipose tissue in vitro oIn the subsequent binding by isolated fat cells suggests that receptor occutpancy bV insUilin in the plasmiia at the time of biopsy cloes not account for intersubject differences. The similarity of the slopes of the Scatchard plots and the fact that the majority of the Hill plots were superimposable implies also that initial degrees of receptor occupancy were similar. This stuidy does not precltude the possibility that, in solime situations, obese inidividuials mav be cliaracterized by different insulin binding affinities. In the presence of negative cooperativity the binding affinity depends uipon the fraction of receptors occuipied. The problem of expressing affinity in these circtumstanices has been mentioned and recently dealt wNith by De Meyts and Roth (26) . With respect to the concentration of insulin required to cautse 50% inhibition of [1251]insulin binding, differences between patients were small and were not systematicallv related to any of the other parameters meastured. It therefore seems uinlikely that receptor affinity is a significanit determinant of the differences in insuilini sensitivity in these obese subjects. It is also of interest that ouir estimaite of 1.26 nM for receptor affinity compares favorably with that of 1.43 obtained by Olefsky et al. (12) for normal fat cells.
It has been proposed (3) that a decrease in instulin receptor concentration miay be an example of negative feedback regulation by circulating inistulin, and evidence is accumulating to suggest that hormone modtulation of hormone receptors is a general physiological phenomenon (3, 30) . Our results, while consistent with this hxpothesis, only show that the number and concentration of insulin receptors per fat cell are closely related to instulin sensitivity or platsma insulin, and do not demonstrate causality. Whether high insulin levels lead to low receptor concentrations or vice versa, or whether both mechanisms might apply in different circumstances, is yet unclear. Furthermore, the significance of the reduced receptor concentrations in terms of insulin-mediated metabolism remains unknown. In any case, since adipose tissue even in obesity accounts for only a small percentage of glucose turnover (31), a decrease in fat cell insulin receptor concentration could not be the cause of insulin resistance in vivo. The changes in fat cells would appear, therefore, to reflect those in more significant insulin target tissues such as the liver. 1440 L. C. Harrison, F. I. R. Martin, and R. A. Melick
Note added in proof. At the time this manuscript was submitted for publication Olefsky (32) reported decreased insulin binding to fat cells and circulating monocytes from obese subjects. Decreased binding was present only in those subjects with hyperinsulinemia. There was a significant inverse correlation between the fasting plasma insulin level and fat cell insulin binding. The present study confirms this relationship and also shows that binding, in particular receptor number, is closely correlated with a direct index of tissue insulin sensitivity, the Kin.
